These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11033603)

  • 21. Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials.
    Krentz AJ; Bailey CJ; Melander A
    BMJ; 2000 Jul; 321(7256):252-3. PubMed ID: 10915108
    [No Abstract]   [Full Text] [Related]  

  • 22. Rosiglitazone and hepatic failure.
    Freid J; Everitt D; Boscia J
    Ann Intern Med; 2000 Jan; 132(2):164. PubMed ID: 10644281
    [No Abstract]   [Full Text] [Related]  

  • 23. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1997 Dec; 278(21):1728. PubMed ID: 9388135
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatotoxicity with thiazolidinediones: is it a class effect?
    Scheen AJ
    Drug Saf; 2001; 24(12):873-88. PubMed ID: 11735645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What caused this patient's sudden liver dysfunction?
    Porterfield LM
    RN; 2001 Mar; 64(3):98. PubMed ID: 11288655
    [No Abstract]   [Full Text] [Related]  

  • 26. Lessons from the glitazones: a story of drug development.
    Gale EA
    Lancet; 2001 Jun; 357(9271):1870-5. PubMed ID: 11410214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of drug induced liver injury related pioglitazone].
    Hisamochi A; Kumashiro R; Koga Y; Tanaka E; Ide T; Hino T; Murashima S; Ogata K; Kuwahara R; Koga H; Shishido S; Ueno T; Sata M; Eguchi T
    Nihon Shokakibyo Gakkai Zasshi; 2003 Mar; 100(3):333-6. PubMed ID: 12696176
    [No Abstract]   [Full Text] [Related]  

  • 28. Did this drug cause my patient's hepatitis?
    Kaplowitz N; Lewis JH; Watkins PB
    Ann Intern Med; 2003 Jan; 138(2):159-60; author reply 159-60. PubMed ID: 12529106
    [No Abstract]   [Full Text] [Related]  

  • 29. A Japanese case of liver dysfunction after 19 months of troglitazone treatment.
    Iwase M; Yamaguchi M; Yoshinari M; Okamura C; Hirahashi T; Tsuji H; Fujishima M
    Diabetes Care; 1999 Aug; 22(8):1382-4. PubMed ID: 10480795
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatocellular injury in a patient receiving pioglitazone.
    Maeda K
    Ann Intern Med; 2001 Aug; 135(4):306. PubMed ID: 11511159
    [No Abstract]   [Full Text] [Related]  

  • 31. Rosiglitazone.
    Diabetes Obes Metab; 2000 Apr; 2(2):117. PubMed ID: 11220523
    [No Abstract]   [Full Text] [Related]  

  • 32. Rezulin pulled in the UK.
    Zurlinden J
    Nurs Spectr (Wash D C); 1998 May; 8(9):25. PubMed ID: 10542729
    [No Abstract]   [Full Text] [Related]  

  • 33. Accelerated hypertension due to rosiglitazone therapy.
    Vikram NK; Misra A; Devi JR
    Indian Heart J; 2002; 54(6):733. PubMed ID: 12674195
    [No Abstract]   [Full Text] [Related]  

  • 34. Mixed hepatocellular-cholestatic liver injury after pioglitazone therapy.
    May LD; Lefkowitch JH; Kram MT; Rubin DE
    Ann Intern Med; 2002 Mar; 136(6):449-52. PubMed ID: 11900497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late-onset troglitazone-induced hepatic dysfunction.
    Bell DS; Ovalle F
    Diabetes Care; 2000 Jan; 23(1):128-9. PubMed ID: 10857986
    [No Abstract]   [Full Text] [Related]  

  • 36. Glitazones, glycemia, and global health status.
    Isley WL
    Diabetes Care; 2001 Dec; 24(12):2158-9. PubMed ID: 11723105
    [No Abstract]   [Full Text] [Related]  

  • 37. Rosiglitazone--useful drug but has side effects.
    Vidhya S; Mohan V
    J Assoc Physicians India; 2002 Apr; 50():615. PubMed ID: 12164432
    [No Abstract]   [Full Text] [Related]  

  • 38. Nonhypoglycemic effects of thiazolidinediones.
    Quesada-Gómez JM; Serrano-Alferez I
    Ann Intern Med; 2001 Dec; 135(11):1007-8. PubMed ID: 11730409
    [No Abstract]   [Full Text] [Related]  

  • 39. Commentary on 'Case series of liver failure associated with rosiglitazone and pioglitazone' by Floyd et al.
    Osei SY; Koro CE; Cobitz AR; Kolatkar NS; Stender M
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1244-6. PubMed ID: 19655316
    [No Abstract]   [Full Text] [Related]  

  • 40. Commentary on 'Case series of liver failure associated with rosiglitazone and pioglitazone' by James Floyd et al.
    Beiderbeck AB; Sakaguchi M
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1247-9. PubMed ID: 19842093
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.